How big is Coherus BioSciences, Inc.?

Jun 22 2025 06:05 PM IST
share
Share Via
As of Jun 18, Coherus BioSciences, Inc. has a market capitalization of 87.88 million and reported net sales of 197.49 million with a net profit of -121.77 million over the latest four quarters. As of Dec 24, shareholder's funds were -131.99 million and total assets were 454.85 million.
As of Jun 18, Coherus BioSciences, Inc. has a market capitalization of 87.88 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 197.49 million, while the sum of net profit for the same period is -121.77 million.

As of Dec 24, the reporting period shows shareholder's funds at -131.99 million and total assets at 454.85 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Coherus BioSciences, Inc. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is Coherus BioSciences, Inc. overvalued or undervalued?
Jun 25 2025 09:05 AM IST
share
Share Via
What does Coherus BioSciences, Inc. do?
Jun 22 2025 06:49 PM IST
share
Share Via